Introduction
Regulatory T (T R ) cells are essential for the maintenance of immunological homeostasis and the effective regulation of immune responses within the body. Given the therapeutic potential of these cells, extensive studies over the last decade have been carried out with the aim of understanding the developmental and functional aspects of T R -cell biology. The most widely studied of these populations are the naturally arising regulatory T (nT R ) cells which develop within the thymus and are characterized by their expression of the forkhead/winged helix transcription factor (Foxp3) and CD25. [1] [2] [3] [4] More recently, accumulating evidence suggests the potential for the extrathymic development of regulatory T-cell populations. [5] [6] [7] [8] The mechanisms by which T R cells mediate their suppressive activity have still to be clearly defined and it is likely that multiple pathways are utilized depending on tissue specificity and the type of immune response being regulated.
In the intestine, the balance between immunity and tolerance is crucial for maintaining the ability to distinguish and respond appropriately to the vast array of dietary antigens, commensal bacteria and harmful pathogens encountered within the gut-associated lymphoid tissue. The importance of T R cells in maintaining this balance is highlighted by studies of human patients with immunodysregulation polyendocrinopathy enteropathy X-linked Christy Toms, 1 Heidi Jessup,
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Keywords: inflammatory bowel disease; mucosal immunity; regulatory T cells; transgenics/knockouts (IPEX) syndrome. 9 In these patients, mutations in the transcription factor Foxp3 result in a lack of functional nT R cells and a primary target of the resulting multiorgan inflammation is the gut. Animal models of colitis have been used to investigate the mechanisms involved in mediating the prevention of intestinal inflammation. Molecules such as transforming growth factor (TGF)-b, interleukin (IL)-10 and cytotoxic T-lymphocyte antigen (CTLA)-4 have all been implicated as playing a role in the suppression of colitogenic T-cell activity mediated by nT R cells, [10] [11] [12] [13] although the exact cell types producing and responding to these immune modulators are still unclear. More recently, specialized subsets of mucosal dendritic cells have been shown to induce the conversion of antigen-specific T cells into Foxp3 + regulatory cells in a retinoic acid and TGF-b dependent manner, 14, 15 providing evidence to suggest that induced as well as natural T R cells act in concert to regulate intestinal immunity.
Gene expression profiling of CD4 + Foxp3 + T R cells has provided valuable insights into the development and function of these cells. [16] [17] [18] [19] One molecule to emerge from these studies is the G-protein coupled receptor Gpr83, which displays highly restricted expression within the nT R -cell subset. Of particular interest is the potential use of Gpr83 as a marker of nT R cells as a consequence of its proposed cell surface expression. Gpr83 was originally identified as a glucocorticoid-responsive gene in a murine thymoma cell line 20 and subsequently shown to display high expression levels within the brain. 21 Whilst the association of Gpr83 with both thymic and peripheral T R -cell subsets has been established, the functional role of Gpr83 remains unclear. Gene expression studies reveal a clear link between Gpr83 expression and Foxp3. 22 Furthermore, retroviral introduction of Foxp3 into naïve CD4 + T cells is sufficient to induce high levels of Gpr83 expression as measured at the mRNA level. 19, 23 More recently, Hansen et al. demonstrated an enhanced ability to induce Foxp3 in cells retrovirally transduced with Gpr83. 23 The physiological significance of this, however, remains to be determined. In this study we have generated mice deficient in Gpr83 expression to further characterize the role of this protein in T R -cell biology.
Materials and methods

Mice
BALB/c, BALB/c Gpr83
)/) , C57BL/6/129 Foxp3 GFP , C57BL/6 dnTGF-bRII, C57Bl/6, BALB/C Ly9Á2 and BALB/c Ly9Á2 RAG2
)/) mice were maintained in specific pathogen-free conditions at the Sir William Dunn School of Pathology (University of Oxford, Oxford, UK). Experiments were conducted in accordance with the UK Scientific Procedures Act 1986.
Purification of CD4 + T-cell subsets CD4 + T cells were purified from spleens by negative depletion using rat anti-mouse CD8 (clone YTS 169), B220 (RA3-6B2), major histocompatibility complex (MHC) class II (TIB 120) and the macrophage marker Mac-1 (M1-70) (all purified from hybridoma supernatants by affinity chromatography), together with antirat coated Dynabeads (Invitrogen, Paisley, UK). CD4 cells were enriched from the thymus by negative depletion using anti-CD8 antibodies and anti-rat coated Dynabeads. Purified CD4 + splenocytes were stained with anti-mouse CD4-CyChrome (clone RM4Á5; BD Biosciences, Erembodegem, Belgium), anti-mouse CD45RB-fluorescein isothiocyanate (FITC) (clone 16A; BD Biosciences) and anti-mouse CD25-phycoerythrin (PE) (clone PC61; BD Biosciences). For purification of CD4 single positive (SP) CD25 + and CD25 ) populations, CD4-enriched thymocytes were stained with CD4-Cyc, CD25-PE and CD8-allophycocyanin (APC) (clone 53-6Á7; BD Biosciences). Subpopulations of CD4 + cells were sorted using a MoFlo (DakoCytomation, Ely, UK) cell sorter. Purified populations were at least > 98Á5% pure upon re-analysis.
T-cell stimulation cultures
] naïve T cells (1 · 10 6 /ml) were activated with either plate-bound anti-CD3 (145-2c11) and anti-CD28 (35Á51) (both at 10 lg/ml) or in some instances with anti-CD3 and anti-CD28 coated beads (Invitrogen). Cells were cultured in complete RPMI (Invitrogen) containing 10% fetal calf serum (FCS), 2 mM L-glutamine, 0Á05 mM 2-mercaptoethanol and 100 U/ml each of penicillin and streptomycin. Where indicated, cells were cultured in the presence of 2 ng/ml recombinant human TGF-b (R&D Systems, Abingdon, UK).
RNA isolation and quantitative polymerase chain reaction (PCR)
RNA was isolated from cells using the RNA Plus Mini Kit (Qiagen, Crawley, UK) and cDNA synthesized using Superscript III (Invitrogen). Quantitative PCR was performed using CD3 gamma chain (CD3c), Gpr83 and Foxp3 specific primers (QuantiTect Primer Assays, Qiagen) and Platinum SYBR Green qPCR Supermix (Invitrogen). cDNA samples were assayed in triplicate using the Chromo4 detection system (GMI, Ramsey, MN), and gene expression levels for each individual sample were normalized to CD3c. Mean relative gene expression was determined and expressed as 2 of genes to hypoxanthine-guanine phosphoribosyl transferase (HPRT).
Generation of Gpr83
)/) transgenic mice
Mice genetically deficient in Gpr83 were generated by homologous recombination in 129-derived embryonic stem (ES) cells using established protocols (Lexicon Genetics, The Woodlands, TX). In brief, a 2374-bp genomic region containing exons 2-3 of Gpr83 (NM_010287) and encoding amino acids 128-215 of the mature polypeptide was deleted by germline cre-mediated excision of a floxed allele. Correct gene targeting and excision were confirmed using Southern blot and PCR analyses. Mice homozygous for the Gpr83 mutation were generated at the expected frequency from heterozygous intercrosses and did not display any overt phenotype. Genotyping was performed using the following primers: GPR83-1, 5 0 -CA GAGCCCGAGTTCTTCCCA-3 0 ; GPR83-6, 5 0 -GGCAGAACC TGGTAACTACTG-3 0 ; and GPR83-11, 5 0 -GCGATAGCT GTCAGAGTC AGT G-3 0 . The mutation was moved from a random hybrid C57BL/5:129 genetic background by five successive backcrosses to BALB/c, using Marker-Assisted backcrossing (Charles River, Wilmington, MA). The resulting mice were homozygous for the BALB/c allele of all sequence length polymorphisms in the MaxBax panel.
Generation of bone marrow chimeras
Bone marrow was isolated from Ly9.2-BALB/c congenic and Gpr83
)/) age-matched mice and mixed at a 1 : 1 ratio. Gamma-irradiated (5.5 Gy, 550 rad) Ly9Á2 RAG2
recipients were injected with 5 · 10 6 mixed bone marrow cells/mouse intravenously. 10 weeks after transfer, T-cell reconstitution was assessed by analysis of expression of the Ly9 allele in peripheral blood.
Colitis induction and histological assessment
Naïve CD4 + CD45RB hi T cells were isolated from BALB/c wild-type and Gpr83
)/) mice and injected intraperito-
recipients (4 · 10 5 /mouse). BALB/c wild-type and Gpr83 )/) CD4 + CD45RB lo CD25 + T cells (2 · 10 5 ) were co-injected i.p. where indicated. Mice were monitored weekly for wasting disease and any mice losing more than 20% of its starting body weight or showing severe signs of disease were killed. Colons were removed from mice 8-10 weeks after T-cell reconstitution and fixed in 10% formalin. Six-micrometre paraffin-embedded sections were cut and stained with haematoxylin and eosin (H&E) and inflammation was assessed using a modified version of a previously described scoring system. 13 Colitis was graded semiquantitatively based on four main criteria: (1) the degree of hyperplasia/goblet cell depletion; (2) the extent of lymphocytic infiltration and inflammation; (3) the percentage area affected, and (4) the presence of severe inflammation as assessed by the presence of submucosal inflammation and crypt abscesses. For each criterion, a score of 0-3 was given and the scores for each criterion added to give a final score of 0-12. Three sections for each colon were taken (proximal, mid and distal) and the colonic score represents the average from individual scores for each of the three sections.
Results
Gpr83 is induced upon T-cell activation
Gpr83 expression profiling has identified Gpr83 as being differentially expressed amongst the CD4 + Foxp3 + T-cell population relative to the Foxp3 ) subset. Quantitative PCR analysis confirms this restricted expression in both thymic and peripheral CD4 + Foxp3 + populations using T-cell subsets isolated from Foxp3 GFP transgenic mice 22 ( Fig. 1a) . These mice express a GFP-Foxp3 fusion protein which can be used to track expression of Foxp3 and thus the isolation of Foxp3 ) (GFP ) ) and Foxp3 + (GFP + ) populations by fluorescence-activated cell sorting (FACS). To determine whether Gpr83 is more widely expressed amongst other immune cell populations, leucocytes were isolated from the spleens of wild-type and BALB/c RAG )/) mice and sorted by FACS into various subsets based on the following markers: CD4, CD8, B220 and DX5. Quantitative PCR analysis revealed that Gpr83 expression was only detectable amongst CD4 + T cells and, as has been shown previously, this was attributable to the enhanced expression of Gpr83 within the CD4 + CD25 + population (Fig. 1b) . A number of markers identified as being enriched within nT R cells have subsequently been shown to be more closely associated with an activatory rather than regulatory phenotype. To investigate whether Gpr83 expression could be detected following the activation of naïve CD4 + T cells we used the Foxp3 GFP transgenic mice. This allowed us to isolate a predominantly naïve population that was negative for expression of Foxp3. Splenic CD4 + CD45RB hi GFP ) naïve T cells were isolated by FACS (purity > 99%) and activated in vitro with aCD3/aCD28 coated beads. Expression of Gpr83 could be detected 24 hr after the activation of these cells, as assessed by quantitative PCR, and had returned to baseline by 72 hr (Fig. 1c ). At its peak the level of expression detected within the naïve T cells was as high as that seen in ex vivo CD45RB lo GFP + nT R cells. Gpr83 appears to be a more acute activation marker as only low levels of GPR83 mRNA were found in the Foxp3
) antigen experi-
) analysed directly ex vivo. In view of the close association observed in T R cells between Foxp3 expression and Gpr83, we also analysed expression of Foxp3 in these cells. Foxp3 mRNA also showed activation-induced induction and was detectable within 24 hr following activation (Fig. 1c) . The level of expression in the activated cells was substantially lower than that seen in CD4 + CD45RB lo CD25 + nT R cells but appeared to be maintained throughout the period of culture. Expression was higher than that observed in the ex vivo CD4 + CD45RB lo CD25 ) T cells, suggesting that this transient induction of Foxp3 was not a general facet of antigen-activated T-cell populations. Taken together, these data show that both Foxp3 and Gpr83 can be induced following the activation of CD4 + Foxp3 ) naïve T cells.
Peripheral induction of Gpr83 is dependent on TGF-b signalling
TGF-b is known to drive the peripheral induction of Foxp3 in activated CD4 + T cells and there is evidence that low levels of Foxp3 detected following activation in vitro reflect a response to TGF-b in the culture medium. To test whether Gpr83 induction was also dependent on TGF-b, naïve CD4 + T cells from mice expressing a dominant negative form of the TGF-b receptor II subunit (dnTGF-bRII), and as such displaying impaired responsiveness to TGF-b, were activated as before and Gpr83 and Foxp3 expression determined by quantitative PCR. As has previously been reported, Foxp3 expression in naïve CD4 + T cells was highly dependent on TGF-b signalling as no detectable Foxp3 mRNA was seen in activated dnTGF-bRII CD4 + T cells. Analysis of Gpr83 expression in these cells clearly showed that, like Foxp3, induction of Gpr83 expression was dependent on TGF-b signalling as no expression could be detected in dnTGF-bRII activated T cells. CD4 + T cells isolated from wild-type mice were able to induce expression of both Foxp3 and Gpr83 and no differences were observed in cell accumulation and viability between wild-type and dnTGF-bRII cultures (data not shown), indicating that the inability to detect expression of Gpr83 and Foxp3 was not a result of a failure to activate these cells, or increased cell death within the culture. Furthermore, as has previously been reported, Foxp3 expression was not reduced in nT R cells isolated from the periphery of dnTGF-bRII mice (Fig. 2b) . 11 However, there was a significant reduction in expression of Gpr83 in dnTGF-bRII nT R cells as compared with wild-type cells. Similar results were seen in CD4 + CD25 + nT R cells isolated from the thymus of dnTGF-bRII mice when compared with wild-type thymic nT R cells (data not shown). These results reveal that, as with Foxp3, expression of Gpr83 is closely associated with TGF-b. Cells were activated with plate-bound aCD3 and aCD28 (both 10 lg/ml) for 48 hr in the presence of recombinant human transforming growth factor (TGF)-b (2 ng/ml). Cells were harvested and re-sorted based on expression of CD4 and GFP (CD4 + GFP ) , > 99% purity; CD4 + GFP + , > 98% purity). (b) RNA was isolated from the sorted populations and quantitative polymerase chain reaction (qPCR) used to determine the relative expression of Foxp3 and Gpr83. CD3c was used as an internal standard and relative mRNA levels normalized to the CD4 + CD45RB hi GFP ) starting population.
Induction of Gpr83 is restricted to Foxp3-expressing cells
Results shown are representative of three independent experiments and are expressed as the mean of triplicate wells ± standard error of the mean (SEM). WT, wild type.
of general T-cell activation, but is tightly linked to Foxp3 expression through a TGF-b-dependent mechanism.
The generation and characterization of Gpr83-deficient mice
To gain an insight into the functional role of Gpr83 in nT R -cell development and function we generated Gpr83-deficient mice. A targeting vector was designed to replace exons 2 and 3 of Gpr83 with a neomycin resistance cassette. In Gpr83 )/) mice, exons 1 and 4 are joined, followed by an immediate stop codon (Fig. 4a) . The predicted protein sequence is truncated after the second transmembrane domain, resulting in a non-functional receptor. Chimeric 'floxed' mice were generated and bred to protamine Cre mice to produce mutant mice. PCR screening was used to determine the transmission of the Gpr83-targeted allele (Fig. 4b) mice as compared with wild type (Fig. 4c ).
Gpr83 expression is not required for the development or peripheral maintenance of nT R cells
To determine whether Gpr83 expression was required for the development of nT R cells, the distribution of CD25 and Foxp3 amongst the CD4 SP thymocytes was assessed by FACS analysis. No differences in total thymic cellularity were detected between wild-type BALB/c age-matched thymi and Gpr83 )/) thymi (data not shown). The development of double-negative, double-positive and CD4 SP and CD8 SP populations was also comparable (data not shown). A lack of Gpr83 expression did not affect the (a) Naïve CD4 + CD45RB hi CD25 ) T cells were isolated from dnTGF-bRII or aged-matched wild-type mice by fluorescence-activated cell sorting (FACS; purity > 98%) and activated in vitro with plate-bound aCD3 and aCD28 (both 10 lg/ml). RNA was isolated at the indicated time-points and forkhead/winged helix transcription factor (Foxp3) and Gpr83 expression analysed by quantitative polymerase chain reaction (qPCR). CD3c was used as an internal standard and relative mRNA amounts were normalized to unactivated (0 hr) expression levels. Results shown are from one of at least three independent experiments and are shown as the mean of triplicate wells ± standard error of the mean (SEM). (b) Splenic CD4 + CD45RB lo CD25 ) and CD25 + populations were isolated from age-matched wild-type and dnTGF-bRII mice. RNA was isolated and qPCR used to determine the relative expression of Foxp3 and Gpr83. As previously, the CD3c chain was used as an internal standard and relative mRNA levels normalized to the CD4 + CD45RB lo green fluorescent protein (GFP) ) populations. Results shown are of one of three independent experiments and are expressed as the mean of triplicate wells ± SEM. Student's t-test was used to determine the statistical significance of differences observed (P < 0Á001).
development of nT R cells as CD4 SP thymocytes from wild-type and Gpr83 )/) mice were equivalent in their expression of CD25 and Foxp3 (Fig. 5a) . Furthermore, the frequency of CD4 SP CD25 + Foxp3 + cells in the CD4 SP CD25
+ populations was also indistinguishable between wild-type (55Á5 ± 1Á7%) and Gpr83 )/) (49Á9 ± 5Á3%) cells (Fig. 5a ). We next asked whether there were changes in the peripheral nT R -cell population. Lymphocytes were isolated from the spleen, mesenteric lymph nodes (MLNs) and colonic lamina propria and analysed by FACS for expression of CD4, CD25 and Foxp3 (Fig. 5b) . Within the spleen, wild-type and Gpr83 )/) lymphocytes expressed equivalent frequencies of CD25 and Foxp3 in the CD4 population. The frequency of CD4 + CD25 + Foxp3 + cells was also similar between wild-type (80Á6 ± 9Á5%) and Gpr83 )/) (81 ± 7Á45%) cells, indicating no overt activation of T cells was occurring in the absence of Gpr83 expression. Whilst the frequency of T R cells within the spleen appeared normal, there was a modest but significant increase in total spleen cell numbers in Gpr83
mice compared with wild type (Fig. 5c ). This was associated with a small, but statistically significant reduction in the overall frequency of CD4 + T cells, whilst total numbers remained the same. The exact nature of the cell type responsible for this increase in spleen cellularity is unclear as there was no detectable difference in the frequencies of B cells, CD8 cells, dendritic cells, monocytes, macrophages or natural killer (NK) cells (data not shown).
Mice lacking Gpr83 remained healthy. Furthermore, there was no histological evidence of colitis (data not shown), indicating that Gpr83 is not crucial for the maintenance of intestinal homeostasis or the effective functioning of nT R cells within the colon or associated lymph nodes. However, it was still possible that differences in the frequency or distribution of nT R cells could result from a defect in Gpr83 function. Within the MLNs, the frequency of CD4 + T cells that were either CD25 + or Foxp3 + was equivalent between wild-type and Gpr83
)/) CD4 + T cells (Fig. 5b) . Moreover, the frequency of CD4 + CD25 + cells that were Foxp3 + was also comparable (wild type, 86Á4 ± 1Á7%; Gpr83 )/) , 81Á1 ± 6Á5%). Within the colon, no differences were observed in the frequencies of CD4 + T cells isolated from the lamina propria of wild-type and Gpr83
)/) mice (data not shown), and the frequencies of CD25 + and Foxp3 + cells within this population were similar. Again, the percentage of CD4 + CD25 + Foxp3 + T cells was also equivalent between the two groups (wild type, 90Á2 ± 3Á1%; Gpr83
, 93Á4 ± 3Á5%). These results indicate that Gpr83 does not play an integral role in the development of nT R cells, nor in the peripheral homeostasis or tissue distribution of these cells under physiological conditions.
Gpr83-deficient bone marrow cells contribute equivalently to the peripheral lymphocyte pool
As the effects of gene deficiency are often revealed in a competition assay with wild-type cells, we next assessed the ability of Gpr83 )/) bone marrow to compete with wild-type bone marrow in repopulating the peripheral T-cell compartment. BALB/c Ly9.2 RAG2 )/) recipients were sublethally irradiated (5.5 Gy) and transferred at a 1 : 1 ratio of wild-type Ly9.2 + bone marrow to Gpr83
Ly9.1 + bone marrow cells. Ten weeks after transfer, mice were killed and the distribution of wild-type and Gpr83-derived T cells analysed. No differences were observed in the ability to reconstitute the peripheral lymphocyte compartment between bone marrow cells lacking Gpr83 expression and wild-type bone marrow, as assessed by the distribution of Ly9. (Fig. 6 ).
Gpr83 is not required for the T R -cell-mediated control of colitis
No obvious deficiencies could be detected in either the development of nT R cells or their function in maintaining intestinal homeostasis under normal conditions. However, it was possible that in a more inflammatory setting there WT and Gpr83-deficient mice were analysed for total cellularity, total CD4 + cell numbers and CD4 + frequency. Mann-Whitney statistical analysis was performed to determine the statistical significance of differences observed. KO, knockout.
Ó )/) CD4 + CD45RB hi T cells induced disease in recipient mice with no observable differences in onset or severity (Fig. 7) . In addition, wild-type and Gpr83 )/)
CD4
+ CD45RB lo CD25 + T R cells were able to effectively suppress the development of disease induced by either wild-type or Gpr83
)/) naïve T cells as assessed by histological analysis of tissue isolated from the colon (Fig. 7) . These results indicate that Gpr83 expression in nT R cells is dispensable for their ability to regulate colitogenic T cells in vivo.
Discussion
Gene expression profiling has identified a number of genes whose expression is highly enriched within the CD4 + Foxp3 + T R -cell subset. Amongst these, the orphan G-protein coupled receptor Gpr83 has been associated with the nT R -cell phenotype. Here we have analysed the expression of Gpr83 and produced Gpr83-deficient mice to critically examine its role in T R -cell development and function. Our results show that Gpr83 expression is tightly linked to Foxp3 expression and that, like Foxp3, its expression in antigen-activated cells is highly TGF-b dependent. Despite this association with Foxp3, Gpr83 appears to be dispensable for nT R -cell development and function. Thus Gpr83-deficient mice had normal frequencies of CD4 + Foxp3 + cells in the primary and secondary lymphoid organs and these cells retained their suppressive activity in vivo in a T-cell transfer model of colitis.
Previous studies suggest Gpr83 expression is restricted to Foxp3 + T cells and is not induced upon activation. 23 By contrast to these results, we found a striking up-regulation of Gpr83, equivalent to levels found amongst nT R cells, following polyclonal activation of naïve CD4 + T cells. Importantly, this induced expression was not associated with a general activation phenotype but was strongly linked with Foxp3, as Gpr83 expression was only detected in activated cells also expressing Foxp3. Furthermore, Gpr83 expression is highly dependent on TGF-b, a cytokine known to induce functional regulatory (iT R ) cells from naïve CD4 + T cells in vitro. 5 Whether TGF-b is acting directly to induce Gpr83 or whether this is a secondary event following induction of Foxp3 is unclear. A recent paper by Hansen et al. has described the preferential induction of Foxp3 in cells retrovirally transduced with Gpr83. 23 This induction occurred under inflammatory conditions, and suggests that Gpr83 may be involved in 'conditioning' cells to express Foxp3 and adopt a regulatory phenotype. However, there does not appear to be an absolute requirement for Gpr83 in the peripheral induction of Foxp3 in vitro, as addition of TGF-b to activated Gpr83-deficient T cells led to similar Foxp3 expression as was observed with wild-type T cells (C. Toms and F. Powrie, unpublished observations). 25 Further experiments are required to clarify a role for Gpr83 in peripheral induction of Foxp3 expression.
TGF-b signalling also sustains Gpr83 expression in nT R cells, as there was a decrease in Gpr83 expression in nT R cells isolated from dnTGF-bRII mice. By contrast, the expression of Foxp3 was comparable between wild-type and dnTGF-bRII nT R cells, suggesting that the latter population does not contain significantly increased numbers of activated non-T R cells, which would reduce the overall expression of Foxp3 within this population. This observation also implies a differential sensitivity of Foxp3 and Gpr83 to TGF-b signalling in nT R cells, especially in the periphery of these mice. It is also notable that Gpr83 expression is highly dependent on IL-2, as nT R cells isolated from mice lacking IL-2 expression show significantly reduced levels of Gpr83. 16 Further studies on the function of Gpr83 would be aided by the identification of the specific ligand for this protein. Preliminary studies have suggested that this may be provided by antigen-presenting cells, 25 although further work is required to definitively demonstrate this. Sequence analysis has revealed that Gpr83 shares the highest sequence homology with members of the neuropeptide Y receptor family, 26, 27 and a recent study demonstrated functional binding of Gpr83 to neuropeptide Y peptide analogues. 28 The in vivo relevance of this has yet to be determined, although there is now increasing evidence for interaction between the neurological and immunological systems within the body.
Despite its strong link to Foxp3 expression, there were no developmental or functional defects in nT R cells derived from mice deficient in Gpr83 expression. These cells could be detected at normal frequency within the thymus and periphery, and the lack of inflammatory disease in these mice suggests no functional abnormalities in nT R cells under steady-state conditions. Similar results have been obtained by Lu et al. 25 However, unlike that study we did find a modest, but significant splenomegaly in mice lacking Gpr83, although the cause or relevance of this remains unclear. Foxp3 + T R cells play a key role in maintaining intestinal homeostasis and this probably involves the activity of thymic-derived and peripherally induced T R -cell populations. Using a T-cell transfer model of colitis we found that CD4 + CD25 + T R cells from Gpr83-deficient mice were able to suppress the development of colitis induced by wild-type or Gpr83 )/) CD45RB hi naïve CD4 + T cells. This result demonstrates, in this in vivo disease model at least, that nT R cells can regulate inflammation in the absence of Gpr83 expression. As Gpr83 is up-regulated in TGF-b-induced Foxp3 iT R cells, it was possible that functional differences in the pathogenicity of Gpr83-deficient CD4 + CD45RB hi T cells would be observed. However, no detectable differences were seen in either the onset or severity of disease induced by wild-type or Gpr83-deficient colitogenic T cells. Comparable levels of Foxp3 could be detected in the CD4 + T cells isolated from CD45RB hi transferred mice, suggesting that there was no defect in the ability to induce Foxp3 in these cells upon transfer (data not shown). Taken together, our data indicate that Gpr83 expression is dispensable for nT R cell function and control of intestinal homeostasis. However, the finding that Gpr83 is a TGF-b-responsive gene highlights a potential role in the peripheral development of Foxp3 + T R cells. Further studies are required to establish this link.
